However, IGFBP-3 and Cr levels were notably lower, and HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) was significantly higher in T2DM-MCI patients compared to T2DM-NCI subjects (p < 0.05) (Table 2). This evidence concerns the gene IGFBP3 and type 2 diabetes mellitus.